The MYC oncoprotein drives cell cycle progression in both normal cells and human tumors. In fact, MYC overexpression provides such a proliferative advantage that a remarkable percentage of human tumors exhibit elevated MYC levels. 1 Hyper-proliferation requires that cells ramp up biosynthetic pathways for protein and lipid production, energy metabolism and DNA replication. Evidence for MYC controlling multiple points in the pathways leading to protein synthesis and energy metabolism has come from a variety of sources in recent years. 2 The study by Mannava published in this issue, along with similar findings from the Dang group, now firmly links MYC to the production of nucleotides required as building blocks for DNA synthesis. After finding that human melanoma cell lines required MYC for optimal proliferation, Mannava et al. identified MYC target genes that might explain this requirement by using expression profiling. Among the targets they identified were genes encoding enzymes that regulate several rate-limiting steps in nucleotide biosynthesis. At least three of these enzymes, thymidylate synthase (TS), inosine monophosphate dehydrogenase 2 (IMPDH2) and phosphoribosyl pyrophosphate synthetase 2 (PRPS2), are encoded by direct MYC target genes. As predicted by this set of observations, MYC depletion resulted in decreased cellular dNTP levels. Using the gold standard for epistatis experiments, Mannava ultimately show that ectopic expression of TS, IMPDH2 and PRPS2 partially rescues the proliferative defect caused by MYC depletion in melanoma cells.These observations are strengthened by the independent findings of the Dang group. Dang et al. also identified IMPDH2 (and IMPDH1) as a MYC target using an unbiased screen for MYC binding sites in the genome. 3 These studies were conducted in different cell types than the melanomas used by Manneva et al. suggesting that the link between MYC and nucleotide biosynthesis holds true across very distinct lineages. More broadly, the Dang group, unlike Manneva et al. found that genes involved in nucleotide metabolism were statistically overrepresented among their list of MYC targets.These two exciting studies appear against the backdrop of previous work linking MYC to this pathway. A number of years ago, similar excitement was generated by evidence that MYC controlled transcription of CAD, 4 the gene encoding the first three enzymes required for pyrimidine biosynthesis. While CAD is clearly regulated by MYC in many settings, subsequent studies showed that its levels were not linked to MYC in Burkitt's lymphoma. 5 Thus, these new studies linking MYC to nucleotide biosynthesis renew optimism that we might now have the mechanistic explanation for how MYC provides one of the essential sets of building blocks necessary as it pushes cell proliferation.Relevant to these findings, a study from the Dalla-Favera group last year showed a role for MYC in the function of origins of DNA replication. 6 Coupled with a role for MYC in generating the nucleotides necessary for DNA synthesis, t...
Silencing receptor GUCY3C tumor suppressor signaling occurs widely in colorectal tumors, reflecting loss of GUCY2C ligand expression. This study identifies a novel b-catenin/ TCF-sensitive locus control region that mediates ligand loss and can be targeted for gene reactivation with CRISPR activation.
The SAGA coactivator complex is essential for eukaryotic transcription and comprises four distinct modules, one of which contains the ubiquitin hydrolase USP22. In yeast, the USP22 ortholog deubiquitylates H2B, resulting in Pol II Ser2 phosphorylation and subsequent transcriptional elongation. In contrast to this H2B‐associated role in transcription, we report here that human USP22 contributes to the early stages of stimulus‐responsive transcription, where USP22 is required for pre‐initiation complex (PIC) stability. Specifically, USP22 maintains long‐range enhancer–promoter contacts and controls loading of Mediator tail and general transcription factors (GTFs) onto promoters, with Mediator core recruitment being USP22‐independent. In addition, we identify Mediator tail subunits MED16 and MED24 and the Pol II subunit RBP1 as potential non‐histone substrates of USP22. Overall, these findings define a role for human SAGA within the earliest steps of transcription.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.